|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.50 USD | +0.09% |
|
-.--% | +159.10% |
| 06-16 | Assertio Holdings Completes Merger With Zydus Lifesciences | MT |
| 06-16 | Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 | CI |
| Market Cap | 152M 132M 123M 113M 213M 14.5B 216M 1.45B 568M 7.22B 570M 558M 24.2B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 129M 112M 104M 95.62M 181M 12.29B 183M 1.23B 482M 6.12B 483M 473M 20.51B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.57% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Assertio Holdings
| 1 day | +0.09% | ||
| 3 months | +27.23% | ||
| 6 months | +91.99% | ||
| Current year | +159.10% |
| Current year | 9.11 |  | 23.5 |
| 1 year | 8.61 | | 23.5 |
| 3 years | 7.71 | | 55.58 |
| 5 years | 7.71 | | 120.15 |
| 10 years | 7.71 | | 1,621.19 |
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 16/06/2026 |
Punit Patel
BRD | Director/Board Member | - | 16/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/5/26 A | Free | Director | 4,851 | 0.0753% | ||
| 3/2/26 A | Free | Chief Financial Officer | 39,932 | 0.6223% | ||
| 2/21/26 A | Fiscal year | Chairperson | 2,852 | 0.0444% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | -.--% | +119.88% | -71.04% | 152M | |
| -2.46% | -7.05% | +44.74% | +147.81% | 1,024B | |
| -1.05% | -5.09% | +47.57% | +47.92% | 618B | |
| -1.84% | -4.25% | +24.75% | +65.04% | 443B | |
| +0.68% | -1.14% | +39.61% | +33.36% | 349B | |
| -1.66% | -3.13% | +31.63% | +39.79% | 297B | |
| -9.28% | -11.08% | +2.91% | +5.14% | 264B | |
| -1.37% | -7.41% | -3.42% | -43.67% | 209B | |
| -1.49% | +0.94% | +25.78% | +64.62% | 208B | |
| -0.17% | -0.50% | +13.41% | +71.94% | 162B | |
| Average | -1.86% | -1.18% | +34.69% | +36.09% | 357.39B | |
| Weighted average by Cap. | -2.07% | -2.17% | +32.74% | +70.13% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 400K 348K 324K 297K 561K 38.18M 570K 3.82M 1.5M 19.01M 1.5M 1.47M 63.74M | - |
| Net Debt | - | - |
Employees
53
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ASRT Stock
Select your edition
All financial news and data tailored to specific country editions
